EpiVax Therapeutics, Inc.

Agent

PRESIDENT

TREASURER

SECRETARY

DIRECTOR

U.S. Small Business Administration Profile

The U.S. Small Business Administration (SBA) helps Americans start, grow, and build resilient businesses.

Note: SBA was created in 1953 as an independent agency of the federal government to aid, counsel, assist and protect the interests of small business concerns; preserve free competitive enterprise; and maintain and strengthen the overall economy of our nation. SBA reviews Congressional and testifies on behalf of small businesses. It assesses the impact of regulatory burden on small businesses.

Form 5500 Series

Events

Filings

Trademarks

Serial Number:

90476634

Mark:

ANCER

Status:

Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.

Mark Type:

Trademark

Application Filing Date:

2021-01-20

Mark Drawing Type:

4 - STANDARD CHARACTER MARK

Mark Literal Elements:

ANCER

USPTO Link:

View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:

Vaccines

International Classes:

005 - Primary Class

Class Status:

ACTIVE

Serial Number:

87561735

Mark:

EPIVAX ONCOLOGY

Status:

Registered. The registration date is used to determine when post-registration maintenance documents are due.

Mark Type:

Service Mark

Application Filing Date:

2017-08-09

Mark Drawing Type:

4 - STANDARD CHARACTER MARK

Mark Literal Elements:

EPIVAX ONCOLOGY

USPTO Link:

View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:

Medical research services in the field of cancer, namely, computational processing of cancer and normal protein sets

First Use:

2019-09-11

International Classes:

042 - Primary Class

Class Status:

ACTIVE

For:

Medical analysis services for the treatment of cancer, namely, analysis of cancer and normal protein sets

First Use:

2019-09-11

International Classes:

044 - Primary Class

Class Status:

ACTIVE

Serial Number:

87294429

Mark:

ANCER

Status:

Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.

Mark Type:

Trademark

Application Filing Date:

2017-01-09

Mark Drawing Type:

4 - STANDARD CHARACTER MARK

Mark Literal Elements:

ANCER

USPTO Link:

View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:

Personalized cancer vaccines

International Classes:

005 - Primary Class

Class Status:

ACTIVE

Serial Number:

87294376

Mark:

EPIVAX ONCOLOGY

Status:

Registered. The registration date is used to determine when post-registration maintenance documents are due.

Mark Type:

Service Mark

Application Filing Date:

2017-01-09

Mark Drawing Type:

4 - STANDARD CHARACTER MARK

Mark Literal Elements:

EPIVAX ONCOLOGY

USPTO Link:

View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:

Research and development of personalized cancer vaccines; medical research in the field of cancer, namely, processing cancer and normal protein sets and identifying high-quality patient specific neo-antigens

First Use:

2019-09-11

International Classes:

042 - Primary Class

Class Status:

ACTIVE

For:

Medical analysis services for the treatment of cancer, namely, processing of cancer and normal protein sets and identifying high-quality patient specific neo-antigens

First Use:

2019-09-11

International Classes:

044 - Primary Class

Class Status:

ACTIVE

Serial Number:

87982539

Mark:

ANCER

Status:

REGISTERED

Mark Type:

TRADEMARK, SERVICE MARK

Application Filing Date:

2017-01-09

Mark Drawing Type:

Standard character mark

Mark Literal Elements:

ANCER

USPTO Link:

View Trademark on United States Patent and Trademark Office Website

Goods And Services

For:

Computer software for processing cancer/normal protein sets, identifying high-quality specific neo-antigens, and designing personalized cancer vaccines

First Use:

2016-12-11

International Classes:

009 - Primary Class

Class Status:

Active

For:

Medical testing and analysis of cancerous and normal protein sets for identifying high-quality patient specific neo-antigens for the purpose of diagnosis and treatment

First Use:

2016-12-11

International Classes:

044 - Primary Class

Class Status:

Active

For:

Research, development, engineering and testing services in the field of personalized cancer vaccines; providing temporary use of non-downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines

First Use:

2016-12-11

International Classes:

042 - Primary Class

Class Status:

Active